KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oscar Health (OSCR) Common Equity (2020 - 2025)

Oscar Health (OSCR) has disclosed Common Equity for 6 consecutive years, with $977.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Common Equity fell 3.55% year-over-year to $977.6 million, compared with a TTM value of $977.6 million through Dec 2025, down 3.55%, and an annual FY2025 reading of $977.6 million, down 3.55% over the prior year.
  • Common Equity was $977.6 million for Q4 2025 at Oscar Health, down from $1.0 billion in the prior quarter.
  • Across five years, Common Equity topped out at $3.6 billion in Q2 2023 and bottomed at -$2.6 billion in Q2 2024.
  • Average Common Equity over 5 years is $765.4 million, with a median of $1.0 billion recorded in 2024.
  • The sharpest move saw Common Equity surged 272.95% in 2021, then plummeted 173.0% in 2024.
  • Year by year, Common Equity stood at -$2.0 billion in 2021, then surged by 100.1% to $2.0 million in 2022, then soared by 45606.05% to $921.4 million in 2023, then increased by 10.0% to $1.0 billion in 2024, then dropped by 3.55% to $977.6 million in 2025.
  • Business Quant data shows Common Equity for OSCR at $977.6 million in Q4 2025, $1.0 billion in Q3 2025, and $13.7 million in Q2 2025.